{"rows":[{"id":64,"title":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","authors":"Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha","journal":"Journal of Affective Disorders","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jad.2026.122063","pubmed_id":"42248535","openalex_id":"https://openalex.org/W7163510976","source_url":"https://doi.org/10.1016/j.jad.2026.122063","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Treatment-Resistant Depression,Veterans","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42248535","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.jad.2026.122063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42248535","source_url":"https://doi.org/10.1016/j.jad.2026.122063","doi":"10.1016/j.jad.2026.122063","pmid":"42248535","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":301,"title":"Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress","authors":"Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki","journal":"Neuropsychopharmacology Reports","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/npr2.70152","pubmed_id":"42379141","openalex_id":"https://openalex.org/W7166665532","source_url":"https://doi.org/10.1002/npr2.70152","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Resilience,Animal Study,Treatment-Resistant Depression","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379141","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/npr2.70152","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379141","source_url":"https://doi.org/10.1002/npr2.70152","doi":"10.1002/npr2.70152","pmid":"42379141","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":46,"title":"Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.","authors":"Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC","journal":"Journal of clinical psychology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/jclp.70167","pubmed_id":"42296474","openalex_id":"https://openalex.org/W7164838909","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42296474","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42296474","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","doi":"10.1002/jclp.70167","pmid":"42296474","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4169,"title":"Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies","authors":"Belle Buzzi","journal":"VCU Scholars Compass (Virginia Commonwealth University)","publication_date":"2026-08-21","publication_year":2026,"doi":"10.25772/0t5k-3r51","pubmed_id":null,"openalex_id":"https://openalex.org/W7127870091","source_url":"https://scholarscompass.vcu.edu/etd/8246","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.25772/0t5k-3r51","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://scholarscompass.vcu.edu/etd/8246","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.25772/0t5k-3r51","source_url":"https://scholarscompass.vcu.edu/etd/8246","doi":"10.25772/0t5k-3r51","pmid":"","publication_date":"2026-08-21","importer_version":"2.1.3","text_redistributed":false}},{"id":3540,"title":"Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial","authors":"Centre for Addiction and Mental Health","journal":"ClinicalTrials.gov","publication_date":"2026-08-21","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07211438","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07211438","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07211438","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07211438","source_url":"https://clinicaltrials.gov/study/NCT07211438","doi":"","pmid":"","publication_date":"2026-08-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5878,"title":"Psilocybin lengthens hippocampal sharp wave ripples","authors":"Bozkir, I. K.; Lashin, R.; Liu, T.; Pal, D.; Diba, K.; Kinsky, N. R.","journal":"bioRxiv","publication_date":"2026-08-20","publication_year":2026,"doi":"10.64898/2026.08.17.745042","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.17.745042","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Neuroplasticity,Receptor Pharmacology","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-08-23 01:20:15","last_checked":"2026-08-23 01:21:56","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.17.745042","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.17.745042","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.08.17.745042","source_url":"https://doi.org/10.64898/2026.08.17.745042","doi":"10.64898/2026.08.17.745042","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5877,"title":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review","authors":"Clark Rachel N","journal":"Lynchburg Journal of Medical Science","publication_date":"2026-08-20","publication_year":2026,"doi":"10.63932/3067-7106.1087","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.63932/3067-7106.1087","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"DOI:10.63932/3067-7106.1087","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.63932/3067-7106.1087","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.63932/3067-7106.1087","source_url":"https://doi.org/10.63932/3067-7106.1087","doi":"10.63932/3067-7106.1087","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":3607,"title":"Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia","authors":"NYU Langone Health","journal":"ClinicalTrials.gov","publication_date":"2026-08-20","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07607938","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Aging,Emotional Processing","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07607938","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07607938","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07607938","source_url":"https://clinicaltrials.gov/study/NCT07607938","doi":"","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5867,"title":"Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services","authors":"Korthuis P. Todd, Cook Ryan R., Gregoire Devin, Stauffer Christopher S., Luoma Jason B., Pertl Kellie, Des Jarlais Don, McCarty Dennis, Levander Ximena A., Hoffman Kim A., Wilson-Poe Adrianne R.","journal":"JAMA Network Open","publication_date":"2026-08-19","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.30608","pubmed_id":"42616497","openalex_id":"https://openalex.org/W7203781486","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Wellbeing,Observational Study,Veterans,Healthcare Workers,Safety","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-08-20 01:20:15","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"PMID:42616497","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42616497","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","doi":"10.1001/jamanetworkopen.2026.30608","pmid":"42616497","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5710,"title":"Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregons state-regulated model","authors":"Gow, A.; Shih, E.; Reid, R.; Qian, J. J.; Mellor, C.; McInnes, L. A.; Carhart-Harris, R.; Davis, J. N.","journal":"medRxiv","publication_date":"2026-08-19","publication_year":2026,"doi":"10.64898/2026.02.18.26346580","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.02.18.26346580","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Observational Study","study_type":"Observational Study","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-07-11 19:28:11","last_checked":"2026-08-23 01:20:34","bibtex":null,"source_record_id":"DOI:10.64898/2026.02.18.26346580","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.02.18.26346580","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.02.18.26346580","source_url":"https://doi.org/10.64898/2026.02.18.26346580","doi":"10.64898/2026.02.18.26346580","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5866,"title":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","authors":"Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements","journal":null,"publication_date":"2026-08-17","publication_year":2026,"doi":"10.5281/zenodo.21983116","pubmed_id":null,"openalex_id":"https://openalex.org/W7203633773","source_url":"https://doi.org/10.5281/zenodo.21983116","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-19 01:20:25","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.5281/zenodo.21983116","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5281/zenodo.21983116","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.21983116","source_url":"https://doi.org/10.5281/zenodo.21983116","doi":"10.5281/zenodo.21983116","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":3472,"title":"A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans","authors":"VA Office of Research and Development","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07226232","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-21 01:27:46","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07226232","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07226232","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07226232","source_url":"https://clinicaltrials.gov/study/NCT07226232","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5862,"title":"Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.","authors":"Meshkat S, Leung M, Meshkat S, Lin Q, Wijendran D, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Monson CM, Vermetten E, Jetly R, Lou W, Zeifman RJ, Bhat V.","journal":"CNS drugs","publication_date":"2026-08-13","publication_year":2026,"doi":"10.1007/s40263-026-01325-5","pubmed_id":"42593636","openalex_id":null,"source_url":"https://doi.org/10.1007/s40263-026-01325-5","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Brain Imaging,Microdosing,Personality Change,Creativity,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-15 01:20:04","last_checked":"2026-08-20 01:20:16","bibtex":null,"source_record_id":"PMID:42593636","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s40263-026-01325-5","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42593636","source_url":"https://doi.org/10.1007/s40263-026-01325-5","doi":"10.1007/s40263-026-01325-5","pmid":"42593636","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3562,"title":"Processing Intergenerational Trauma With Psilocybin-Assisted Therapy","authors":"Rachel Yehuda","journal":"ClinicalTrials.gov","publication_date":"2026-08-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06899165","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Biomarkers,Wellbeing,Resilience,Healthcare Workers,Safety","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-20 01:29:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06899165","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06899165","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06899165","source_url":"https://clinicaltrials.gov/study/NCT06899165","doi":"","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3539,"title":"The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder","authors":"Sharmin Ghaznavi","journal":"ClinicalTrials.gov","publication_date":"2026-08-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06247839","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Aging","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-20 01:29:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06247839","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06247839","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06247839","source_url":"https://clinicaltrials.gov/study/NCT06247839","doi":"","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5856,"title":"Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)","authors":"Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria","journal":"Journal of Clinical Medicine","publication_date":"2026-08-12","publication_year":2026,"doi":"10.3390/jcm15166228","pubmed_id":null,"openalex_id":"https://openalex.org/W7202254245","source_url":"https://doi.org/10.3390/jcm15166228","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-13 01:20:21","last_checked":"2026-08-19 01:20:25","bibtex":null,"source_record_id":"DOI:10.3390/jcm15166228","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/jcm15166228","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/jcm15166228","source_url":"https://doi.org/10.3390/jcm15166228","doi":"10.3390/jcm15166228","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3684,"title":"TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy","authors":"M.D. Anderson Cancer Center","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06200155","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06200155","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06200155","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06200155","source_url":"https://clinicaltrials.gov/study/NCT06200155","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3674,"title":"TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors","authors":"M.D. Anderson Cancer Center","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06801041","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06801041","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06801041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06801041","source_url":"https://clinicaltrials.gov/study/NCT06801041","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3581,"title":"Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality","authors":"The University of Texas Health Science Center, Houston","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06706232","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06706232","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06706232","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06706232","source_url":"https://clinicaltrials.gov/study/NCT06706232","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}}],"total":1741,"page":1,"per_page":20,"pages":88,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Depression","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}